PULIKE(SH:603566) Zheng Quan Shi Bao Wang·2025-10-13 08:15Core Viewpoint - The approval of "Fluralaner Drops" as a new veterinary drug by the Ministry of Agriculture and Rural Affairs marks a significant development for the company and its wholly-owned subsidiary, Luoyang Huizhong Veterinary Medicine Co., Ltd, as it addresses a gap in the market for flea and tick treatment in cats [1] Company Summary - The company, 普莱柯 (603566), has received official approval for its new veterinary drug, "Fluralaner Drops," which is intended for the treatment of flea and tick infections in cats [1] - The drug has been registered and the registration certificate was publicly announced on October 11 [1] Industry Summary - As of now, there are no similar products available in the market, indicating a potential competitive advantage for the company in the veterinary pharmaceutical sector [1]